Showing 1 - 14 results of 14 for search 'Nanthapisal S', query time: 0.04s
Refine Results
-
1
-
2
C1q deficiency in activated PI3Kδ syndrome type 2. by Kimberly Gilmour, Carsten Speckmann, Peter Olbrich, Sira Nanthapisal, Ying Hong
Published 2019-11-01
Article -
3
-
4
Continuous versus intermittent short-acting β2-agonists nebulization as first-line therapy in hospitalized children with severe asthma exacerbation: a propensity score matching ana... by Prapasri Kulalert, Phichayut Phinyo, Jayanton Patumanond, Chutima Smathakanee, Wantida Chuenjit, Sira Nanthapisal
Published 2020-07-01
Article -
5
-
6
-
7
-
8
Minimum number and types of allergens for a skin prick test panel in Thai children with allergic respiratory diseases by Prapasri Kulalert, Orapan Poachanukoon, Sira Nanthapisal, Paskorn Sritipsukho, Karnsinee Thanborisutkul, Pasistha Termworasin, Rungrawee Kornsawai, Patcharaporn Punyashthira
Published 2022-08-01
Article -
9
A Randomized Clinical Trial of a Fractional Low Dose of BNT162b2 Booster in Adults Following AZD1222 by Rapisa Nantanee, Watsamon Jantarabenjakul, Peera Jaru-Ampornpan, Pimpayao Sodsai, Orawan Himananto, Jitthiwa Athipunjapong, Jiratchaya Sophonphan, Sira Nanthapisal, Nattiya Hirankarn, Thanyawee Puthanakit
Published 2022-06-01
Article -
10
Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine by Auchara Tangsathapornpong, Sira Nanthapisal, Kanassanan Pontan, Pornumpa Bunjoungmanee, Yamonbhorn Neamkul, Arthit Boonyarangkul, Supattra Wanpen, Waraphon Fukpho, Sumana Jitpokasem, Phuntila Tharabenjasin, Peera Jaru-Ampornpan
Published 2023-02-01
Article -
11
Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants by Suvimol Niyomnaitham, Anan Jongkaewwattana, Atibordee Meesing, Nawamin Pinpathomrat, Sira Nanthapisal, Nattiya Hirankarn, Sarawut Siwamogsatham, Suppachok Kirdlarp, Romanee Chaiwarith, Saranath Lawpoolsri, Supranee Phanthanawiboon, Arunee Thitithanyanont, Pokrath Hansasuta, Sansanee Chaiyaroj, Punnee Pitisuttithum
Published 2023-04-01
Article -
12
Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study by Paskorn Sritipsukho, Thana Khawcharoenporn, Boonying Siribumrungwong, Pansachee Damronglerd, Nuntra Suwantarat, Araya Satdhabudha, Chanapai Chaiyakulsil, Phakatip Sinlapamongkolkul, Auchara Tangsathapornpong, Pornumpa Bunjoungmanee, Sira Nanthapisal, Chamnan Tanprasertkul, Naiyana Sritipsukho, Chatchai Mingmalairak, Anucha Apisarnthanarak, Pichaya Tantiyavarong
Published 2022-12-01
Article -
13
Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need? by Paskorn Sritipsukho, Thana Khawcharoenporn, Boonying Siribumrungwong, Pansachee Damronglerd, Nuntra Suwantarat, Araya Satdhabudha, Chanapai Chaiyakulsil, Phakatip Sinlapamongkolkul, Auchara Tangsathapornpong, Pornumpa Bunjoungmanee, Sira Nanthapisal, Chamnan Tanprasertkul, Naiyana Sritipsukho, Chatchai Mingmalairak, Anucha Apisarnthanarak, Pichaya Tantiyavarong
Published 2023-12-01
Article -
14
Janus kinase inhibition for autoinflammation in DNASE2 deficiency by Hong, Y, Capitani, M, Murphy, C, Pandey, S, Cavounidis, A, Takeshita, H, Nanthapisal, S, Yasuda, T, Bader-Meunier, B, McCreary, D, Omoyinmi, E, Rao, A, Booth, C, Gilmour, K, Sebire, N, Shah, N, Klein, N, Bullock, A, Eleftheriou, D, Uhlig, H, Brogan, P
Published 2019Journal article